Skip to main content
Revista Panamericana de Salud Pública logoLink to Revista Panamericana de Salud Pública
. 2023 Jun 30;47:e100. doi: 10.26633/RPSP.2023.100

Factors associated with COVID-19 length of hospitalization and mortality during four epidemic waves, March 2020–November 2021, Suriname

Factores asociados a la duración de la hospitalización y la mortalidad por COVID-19 en cuatro oleadas epidémicas, de marzo del 2020 a noviembre del 2021 en Suriname

Fatores associados à duração da internação e à mortalidade por COVID-19 durante quatro ondas epidêmicas, de março de 2020 a novembro de 2021, no Suriname

Anisma R Gokoel 1,, Maniesha Jairam 1, Angele Mendeszoon 2, Lindy Liauw Kie Fa 1, Fauzia Poese 1, Ameerani Jarbandhan 3, Vanita Jairam 1, Firoz Abdoel Wahid 4
PMCID: PMC10292672  PMID: 37396461

ABSTRACT

Objectives.

To determine the sociodemographic risk factors associated with coronavirus disease 2019 (COVID-19) mortality in Suriname.

Methods.

This was a retrospective cohort study. All registered deaths from COVID-19 in Suriname (n=1112) between March 13, 2020 and November 11, 2021 were included. Data were collected from medical records and included demographic variables and hospitalization duration of patients who died. Descriptive statistics, chi-squared tests, ANOVA models, and logistic regression analyses were used to determine associations between sociodemographic variables, length of hospitalization, and mortality during four epidemic waves.

Results.

The case fatality rate over the study period was 22 per 1 000 population. The first epidemic wave was from July to August 2020, the second from December 2020 to January 2021, the third from May to June 2021, and the fourth from August to September 2021. Significant differences were found in the number of deaths and hospitalization duration by wave (p<0.001). Patients were more likely to have a longer hospitalization during the first (OR 1.66; 95% CI: 0.98, 2.82) and third waves (OR 2.37; 95% CI: 1.71, 3.28) compared with the fourth wave. Significant differences in mortality were also seen between ethnicities by wave (p=0.010). Compared with the mixed and other group, people of Creole ethnicity (OR 2.7; 95% CI: 1.33, 5.29) and Tribal people (OR 2.8; 95% CI: 1.12, 7.02) were more likely to die during the fourth wave than the third wave.

Conclusions.

Tailored interventions are needed for males, people of Creole descent, Tribal and Indigenous peoples, and people older than 65 years.

Keywords: COVID-19, mortality, social determinants of health, Suriname


Globally, the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affected the social and economic landscape (1), and greatly affected the Caribbean region (2).

Recent data (December 2022) show that 639 572 819 confirmed cases of COVID-19 and 6 615 258 deaths occurred worldwide (3). Most deaths were reported in elderly people, who were more likely to develop acute respiratory distress syndrome and require mechanical ventilation. Studies in China and Brazil show that most deaths were in men, people aged 65 years and older, and those with with comorbidities (4, 5). This higher mortality rate in men was also observed in Ecuador (6). Other studies found racial differences in the proportion of cases and death rates, such as in Black and Hispanic people living in the USA. Higher mortality rates appear to be related to income, poverty, and working in the health care and essential service sector (7).

From the start of the COVID-19 pandemic, many epidemic waves have been recorded. Studies have shown that the different epidemic waves were largely related to the different circulating variants of SARS-CoV-2, which led to variability in morbidity and mortality. In Israel and Malaysia, the third COVID-19 wave had more confirmed cases and deaths compared with the first and second waves (8, 9). In Japan, the overall severity in the fourth wave was higher than the first three waves; however this did not result in a significant difference in mortality (10). In most countries, the total number of deaths in waves three and four were similar or higher than in wave two (11). In general, the delta variant was the dominant variant in epidemic waves three and four.

Suriname is a middle-income Caribbean country. Similar to other countries in this region (12), pressure on the health care system has far-reaching consequences, making public health planning and hospital management particularly important. Suriname is among the countries in the Caribbean region with the highest mortality rate from COVID-19 (206.07 deaths per 100 000 inhabitants), higher than Ecuador (193.97 per 100 000 inhabitants), Guyana (136.69 per 100 000 inhabitants), and Uruguay (178.87 per 100 000 inhabitants) (12). Suriname had its first COVID-19 death in April 2020. From the start of the epidemic in Suriname in March 2020 until November 2021, four different COVID-19 waves occurred, which resulted in 1 166 registered deaths and 50 760 COVID-19 cases up to November 30, 2021 (13). While the COVID-19 epidemic placed a heavy burden on the already fragile health care system and hence required rigorous health planning, no studies have yet been conducted on COVID-19 morbidity and mortality in Suriname. The objective of this study therefore was to identify sociodemographic risk factors for death from COVID-19 in Suriname.

METHODS

Our study was a retrospective cohort design. All people who died of COVID-19 in Suriname (n=1 112) between March 13, 2020 (epidemiological week 14) and November 11, 2021 (epidemiological week 46) were included in this study. This was regardless of nationality, residency or legal status. For hospital deaths, data were obtained from the records of all hospitals in Suriname, namely: the Academic Hospital Paramaribo; Diakonessenhuis Hospital; Medical Mungra Centre; Regional Hospital Wanica; ‘s Lands Hospital; and St Vincentius Hospital (Figure 1). The non-hospital deaths were patients who died at home or at a primary health care clinic (Regional Health Services clinic or Medical Mission Primary Health Care Suriname clinic). The diagnosis of COVID-19 was confirmed by a positive result for SARS-CoV-2 based on a polymerase chain reaction test. Patients with a positive COVID-19 diagnosis who were hospitalized or admitted to a primary health care clinic were included in the study.

FIGURE 1. Diagram of COVID-19 deaths in Suriname.

FIGURE 1.

COVID-19, coronaviruse disease 2019; ICU, intensive care unit.

Source: prepared by authors from results taken from published data.

The data collected included demographic variables (age, sex, ethnicity, and place of residence) and information on the date of admission and death. The duration of hospitalization was defined as the period between the date of admission and date of death. Ethnicity was self-reported and categorized as follows: Chinese, Creole (of African descent mixed with any other race), Hindustani, Indigenous, Javanese, Tribal (of African descent), and other (mixed, Caucasians). Region was categorized as: urban (Paramaribo and Wanica); rural (Nickerie, Coronie, Saramacca, Commewijne, and Para); and Hinterlands of Suriname (Marowijne, Brokopondo, and Sipaliwini). The classification of region is according to the General Bureau of Statistics (14). The mortality rate by age, sex, and ethnicity was expressed per 10 000 people with the latest census data from 2012 from the Bureau of Statistics (14).

During the study period, four epidemic waves were identified in Suriname by the Ministry of Health (15), based on number of people with positive COVID-19 tests. The first wave was from July to August 2020, the second wave from December 2020 to January 2021, the third from May to June 2021 and the fourth from August to September 2021. For this study, we distinguished waves based on mortality and called these fatality waves.

Statistical analysis

Data were analyzed using SPSS, version 20 (IBM Corp., Armonk, NY, USA). Descriptive statistics include absolute values, relative frequencies, and mortality rates per 10 000 inhabitants. The one-sample chi-squared test was used to determine differences in the number of deaths per wave for each independent variable. Bivariate logistic regression analysis was used to determine an association between duration of hospitalization and wave. Chi-squared tests and ANOVA models were used to examine differences between the independent variables during the four waves. A multivariable logistic regression analysis was used to estimate the magnitude of the relationship between ethnicity and mortality in the second, third and fourth waves compared with the first COVID-19 wave. Odds ratios (OR) and 95% confidence intervals (CI) are given. A p-value ≤0.05 was considered statistically significant. The case fatality rate was calculated by dividing the number of confirmed deaths by the number of confirmed cases during the study period (3).

Ethical considerations

This study was approved by the Medical Ethical Commission of Suriname’s Ministry of Health. Consent was waived because the study was a secondary analysis of de-identified data.

RESULTS

Table 1 shows the demographic characteristics of the the people who died from COVID-19. The median age was 66 years (interquartile range 56.0–75.5 years), with a range of 17–100 years. Of the people who died, 52.6% were aged ≥65 years, 56.2% were males, and 29.0% were of Creole ethnicity, followed by 26.8% of Hindustani ethnicity. Most of the patients lived in urban areas (76.8%). The highest mortality rates were among the Indigenous peoples and people of Creole ethnicity, both 34 deaths per 10 000, followed by people of Javanese ethnicity (24 deaths per 10 000).

TABLE 1. Deaths from COVID-19 and mortality rate by sociodemographic characteristics, Suriname.

Characteristic (n=1112)

n (%)

Population, N

Mortality rate (deaths per 10 000)

Age, in yearsa

 

 

 

15–24

9 (0.9)

93 950

1

25–34

35 (3.5)

85 000

4

35–44

59 (5.8)

75 530

8

45–54

129 (12.7)

59 870

22

55–64

248 (24.5)

39 400

63

65–74

260 (25.7)

22 490

116

≥70

273 (26.9)

12 250

223

Missing

99 (–)

NA

NA

Sex

 

 

 

Male

574 (56.2)

27 2690

21

Female

447 (43.8)

26 7220

17

Missing

91 (–)

NA

NA

Ethnicity

 

 

 

Creole

291 (29.0)

84 933

34

Hindustani

269 (26.8)

148 443

18

Indigenous

70 (7.0)

20 344

34

Javanese

181 (18.0)

73 975

24

Tribal

75 (7.5)

117 567

6

Mixed and other

117 (11.7)

87 391

13

Missing

109 (–)

NA

NA

Region

 

 

 

Urban

514 (76.8)

361 736

14

Rural

129 (19.3)

111 224

12

Interior

26 (3.9)

71 268

4

Missing

443 (–)

NA

NA

COVID-19, coronaviruse disease 2019; NA, not applicable.

a

Median age was 66 years.

Source: Prepared by authors from the results, based on published data.

Figure 2 shows the epidemic waves based on confirmed cases and the fatality waves from March 2020 until November 2021. The overall case fatality rate of COVID-19 was 22 per 1 000 positive COVID-19 cases. The number of deaths in each wave (and as a proportion of all deaths during the study period) is as follows: 74 (6.7%, first wave), 38 (3.4%, second wave), 391 (35.2%, third wave), and 304 (27.3%, fourth wave). The number of deaths per wave differed significantly (p<0.001).

FIGURE 2. Trend in COVID-19 cases and deaths during the four epidemic waves, March 2020–November 2021, Suriname.

FIGURE 2.

COVID-19, coronaviruse disease 2019.

Source: prepared by authors from results taken from published data.

Table 2 shows the sociodemographic characteristics of hospitalized patients who died in the four waves. The median age of patients in these waves varied between 65 and 70 years. The median duration of hospitalization differed significantly by the fatality wave (p<0.001). Patients were more likely to have a longer hospitalization duration (above the median) during the first (OR 1.66; 95% CI: 0.98, 2.82) and third fatality waves (OR 2.37; 95% CI: 1.71, 3.28) compared with the fourth wave. Although not significant, more male patients died of COVID-19 than female patients during each fatality wave. A significant association was seen between the different ethnicities and the four fatality waves (p=0.010). When compared with the mixed and other groups, patients of Creole ethnicity (OR 2.7; 95% CI: 1.33, 5.290; p=0.006) and Tribal people (OR 2.8; 95% CI: 1.12, 7.02; p=0.028) were more likely to die during the fourth wave than the third wave.

TABLE 2. Sociodemographic characteristics of hospitalized patients who died from COVID-19 by epidemic wave, Suriname.

Characteristic

Wave

p-value

One (week 31–37, 2020)

Two (week 2–6, 2021)

Three (week 17–28, 2021)

Four (week 35–42, 2021)

Median age, in years

66

70

65

66

0.437

Median duration of hospitalization, in days

7.0

3.5

6.0

3.0

0.001

Sex, n (%)

 

 

 

 

0.294

Male

48 (64.9)

24 (63.2)

209 (54.3)

143 (55.0)

 

Female

26 (35.1)

14 (36.8)

176 (45.7)

117 (45.0)

 

Ethnicity, n (%)

 

 

 

 

0.010

Creole

16 (22.5)

8 (22.9)

106 (28.3)

100 (38.5)

 

Hindustani

14 (19.7)

9 (25.7)

100 (26.7)

68 (26.2)

 

Indigenous

11 (15.5)

4 (11.4)

18 (4.8)

16 (6.2)

 

Javanese

13 (18.3)

6 (17.1)

80 (21.3)

36 (13.8)

 

Tribal

7 (9.9)

3 (8.6)

21 (5.6)

17 (6.5)

 

Others

10 (14.1)

5 (14.3)

50 (13.3)

23 (8.8)

 

Region, n (%)

 

 

 

 

0.846

Urban

36 (80.0)

13 (81.2)

(162 (77.9)

155 (76.7)

 

Rural

6 (13.3)

3 (18.8)

39 (18.8)

40 (19.8)

 

Interior

3 (6.7)

0 (0.0)

7 (3.4)

7 (3.5)

 

COVID-19, coronaviruse disease 2019.

Source: Prepared by authors from the results, based on published data.

DISCUSSION

This study examined the COVID-19 mortality rate and its associated sociodemographic determinants, as well as hospitalization duration, between the COVID-19 epidemic waves in Suriname. As expected, the so-called fatality waves closely followed the epidemic waves in time and distribution. The case fatality rate of COVID-19 in Suriname was 22 per 1 000 cases. This rate was 0.018 deaths per 1 000 in Paraguay (16). Notably, our study showed that more deaths were recorded in the third and fourth waves. A possible explanation for this may be the different variants that emerged after the second epidemic wave, potentially causing higher mortality in Suriname. The P1, B1.1.7, and B1.351 variants were confirmed during these epidemic waves, as well as the delta variant during the third epidemic wave in Suriname (17, 18). The COVID-19 variants were assessed through genomic surveillance.

Proportionally more people of Creole descent and Indigenous peoples died of COVID-19 in Suriname. These higher rates are in line with other studies showing higher mortality rates in Black people and Indigenous populations (7, 19). Significantly more people of Creole descent and Tribal peoples died than people of mixed and other ethnicity during the fourth fatality wave compared with the third fatality wave. Underlying factors may relate to a lack of access to or use of health care services, social determinants such as poor work safety, poverty, and crowded housing (20, 21), as well as pre-existing health conditions and biological susceptibilities (22, 23).

Most of the people who died were men, a finding that concurs with other studies (5, 6). However, it should be noted that an increase in the number of women who died was seen in the third and fourth fatality waves. This finding may be related to the type of variants that were circulating during the corresponding epidemic waves. We also found that mortality was highest in patients 65 years and older, which is consistent with other studies (4, 5). Our study showed a significantly longer duration of hospitalization during the first and third waves, compared with the second wave. These differences may be explained by the changed virulence and pathogenicity of the circulating variants.

A strength of our study is that it included all registered deaths from COVID-19, from the start of the epidemic in Suriname until November 2021. Another strength is that the data were retrospectively collected in a short period of time using the hospital databases. We were therefore able to analyze the most recent data. Since almost 90% of the COVID-19 deaths occurred in hospitals, our results can be seen as representative of the Surinamese population. A limitation of our study was that data on all people in Suriname who tested positive for COVID-19 were not available. Therefore, we could not compare our results with the demographic variables of all confirmed cases or the waves as defined by the Ministry of Health. While most of the data were readily available, there was a backlog in entry of some data, such as on comorbidities. This was due to the effects of the epidemic on personnel with more sick leave and higher workloads. It should be noted that an important proportion of people may have had COVID-19 but were asymptomatic. Our study focused on hospitalized and thus symptomatic patients; hence asymptomatic people were not included.

Conclusion

This study showed that important sociodemographic differences in COVID-19 mortality rates exist in Suriname. Based on our findings, groups that can be identified as vulnerable are: men; people aged 65 years and older; people of Creole descent; and Tribal and Indigenous peoples. These groups require tailored interventions. The duration of hospitalization related to the different waves and circulating variants during the COVID-19 epidemic in Suriname also highlights that close monitoring of variants can help inform health planning. To gain further insight into the spread and effect of COVID-19 in Suriname, future studies should assess knowledge, attitudes, and behaviors of the Surinamese population regarding COVID-19, and include other sociodemographic factors, such as income, comorbidities, and vaccination status.

Disclaimer.

The authors hold sole responsibility for the views expressed in the manuscript, which may not necessarily reflect the opinion or policy of the Revista Panamericana de Salud Pública / Pan American Journal of Public Health and/or those of the Pan American Health Organization.

Acknowledgements.

We thank the Ministry of Health in Suriname and all the hospitals in Suriname.

Footnotes

Author contributions.

All authors conceived the original idea, collected and analyzed the data, interpreted the results, and wrote and reviewed the paper. All authors reviewed and approved the final version.

Conflicts of interest.

None declared.

Corrigendum: The Pan American Journal of Public Health draws readers’ attention to an error in the following article, pointed out by the authors:

Byline and suggested citation in page 1 last name of co-author should read Jarbandhan instead of Jarbanha

REFERENCES

  • 1.Oyedotun T, Moonsammy S. Spatiotemporal variation of COVID-19 and its spread in South America: a rapid assessment. Ann Am Assoc Geogr. 2020;111(6):1868–79. doi: 10.1080/24694452.2020.1830024. [DOI] [Google Scholar]; Oyedotun T, Moonsammy S. Spatiotemporal variation of COVID-19 and its spread in South America: a rapid assessment. Ann Am Assoc Geogr. 2020;111(6):1868–79. doi: 10.1080/24694452.2020.1830024
  • 2.de Souza W, Buss L, da Silva Candido D, Carrera J, Li S, Zarebski A, et al. Epidemiological and clinical characteristics of the covid -19 epidemic in Brazil. Nat Hum Behav. 2020;4(8):856–65. doi: 10.1038/s41562-020-0928-4. [DOI] [PubMed] [Google Scholar]; de Souza W, Buss L, da Silva Candido D, Carrera J, Li S, Zarebski A, et al. Epidemiological and clinical characteristics of the covid -19 epidemic in Brazil. Nat Hum Behav. 2020;4(8):856–65. doi: 10.1038/s41562-020-0928-4 [DOI] [PubMed]
  • 3.World Health Organization WHO coronavirus (COVID-19) dashboard. [cited 2021 Dec 8]. internet. Available from: https://covid19.who.int/; World Health Organization. WHO coronavirus (COVID-19) dashboard [internet]. [cited 2021 Dec 8]. Available from: https://covid19.who.int/
  • 4.Marcolino M, Ziegelmann P, Souza-Silva M, Nascimento I, Oliveira L, Monteiro L, et al. Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: results from the Brazilian COVID-19 registry. Int J Infect Dis. 2021;107:300–10. doi: 10.1016/j.ijid.2021.01.019. [DOI] [PMC free article] [PubMed] [Google Scholar]; Marcolino M, Ziegelmann P, Souza-Silva M, Nascimento I, Oliveira L, Monteiro L, et al. Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: results from the Brazilian COVID-19 registry. Int J Infect Dis. 2021;107:300–10. doi: 10.1016/j.ijid.2021.01.019. [DOI] [PMC free article] [PubMed]
  • 5.Yao T, Gao Y, Cui Q, Peng B, Chen Y, Li J, et al. Clinical characteristics of a group of deaths with COVID-19 pneumonia in Wuhan, China: a retrospective case series. BMC Infect Dis. 2020;20(695):695. doi: 10.1186/s12879-020-05423-7. [DOI] [PMC free article] [PubMed] [Google Scholar]; Yao T, Gao Y, Cui Q, Peng B, Chen Y, Li J, et al. Clinical characteristics of a group of deaths with COVID-19 pneumonia in Wuhan, China: a retrospective case series. BMC Infect Dis. 2020;20(695):695. doi: 10.1186/s12879-020-05423-7 [DOI] [PMC free article] [PubMed]
  • 6.Ortiz-Prado E, Simbana-Riveira K, Gomez Barreno L, Diaz A, Barreto A, Moyano C, et al. Epidemiological, socio-demographic and clinical features of the early phase of the COVID-19 epidemic in Ecuador. PLoS Negl Trop Dis. 2021;15:1–18. doi: 10.1371/journal.pntd.0008958. [DOI] [PMC free article] [PubMed] [Google Scholar]; Ortiz-Prado E, Simbana-Riveira K, Gomez Barreno L, Diaz A, Barreto A, Moyano C, et al. Epidemiological, socio-demographic and clinical features of the early phase of the COVID-19 epidemic in Ecuador. PLoS Negl Trop Dis. 2021;15:1–18. doi: 10.1371/journal.pntd.0008958 [DOI] [PMC free article] [PubMed]
  • 7.Kim B, Rundle A, Goodwin A, Morrison C, Branas C, El-Sadr W, et al. COVID-19 testing, case, and death rates and spatial socio-demographics in New York City: an ecological analysis as of June 2020. Health Place. 2021;68:102539. doi: 10.1016/j.healthplace.2021.102539. [DOI] [PMC free article] [PubMed] [Google Scholar]; Kim B, Rundle A, Goodwin A, Morrison C, Branas C, El-Sadr W, et al. COVID-19 testing, case, and death rates and spatial socio-demographics in New York City: an ecological analysis as of June 2020. Health Place. 2021;68:102539. doi: 10.1016/j.healthplace.2021.102539 [DOI] [PMC free article] [PubMed]
  • 8.Feinberg A, Loyola A, Sima M, Tom C, Yang K. ULAB PHHS. An epidemiological comparison of COVID-19 waves in Malaysia. UC Berkeley: Public Health & Health Science Division; 2021. [Google Scholar]; Feinberg A, Loyola A, Sima M, Tom C, Yang K, & ULAB PHHS. An epidemiological comparison of COVID-19 waves in Malaysia. UC Berkeley: Public Health & Health Science Division; 2021.
  • 9.Niv Y, Eliakim-Raz N, Bar-Lavi Y, Green M, Dreiher J, Hupert A, et al. Comparing Covid-19 pandemic waves in hospitalized patients – a retrospective, multicenter, cohort study. Clin Infect Dis. 2022;75(1):e389–96. doi: 10.1093/cid/ciac119. [DOI] [PMC free article] [PubMed] [Google Scholar]; Niv Y, Eliakim-Raz N, Bar-Lavi Y, Green M, Dreiher J, Hupert A, et al. Comparing Covid-19 pandemic waves in hospitalized patients – a retrospective, multicenter, cohort study. Clin Infect Dis. 2022;75(1):e389–96. doi: 10.1093/cid/ciac119 [DOI] [PMC free article] [PubMed]
  • 10.Kurahara Y, Kobayashi T, Shintani S, Matsuda Y, Tamiya A, Sugwara R, et al. Clinical characteristics of COVID-19 in Osaka, Japan: comparison of the first–third waves with the fourth wave. Respir Investig. 2021;59(6):810–8. doi: 10.1016/j.resinv.2021.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]; Kurahara, Y, Kobayashi T, Shintani S, Matsuda Y, Tamiya A, Sugwara R, et al. Clinical characteristics of COVID-19 in Osaka, Japan: comparison of the first–third waves with the fourth wave. Respir Investig. 2021;59(6):810–8. doi: 10.1016/j.resinv.2021.08.005 [DOI] [PMC free article] [PubMed]
  • 11.Cruz Castanheira H, Costa Monteira da Silva J, Del Popolo F, Bay G, Saad P. Evidence and scenarios. Economic Commission for Latin America and the Caribbean (ECLAC); 2021. Covid-19 mortality. [Google Scholar]; Cruz Castanheira H, Costa Monteira da Silva J, Del Popolo F, Bay G, Saad P. Covid-19 mortality. Evidence and scenarios. Economic Commission for Latin America and the Caribbean (ECLAC); 2021.
  • 12.Schwalb A, Armyra E, Méndez-Aranda M, Ugarte-Gil C. COVID-19 in Latin America and the Caribbean: two years of the pandemic. J Intern Med. 2022;292(3):409–27. doi: 10.1111/joim.13499. [DOI] [PMC free article] [PubMed] [Google Scholar]; Schwalb A, Armyra E, Méndez-Aranda M, Ugarte-Gil C. COVID-19 in Latin America and the Caribbean: two years of the pandemic. J Intern Med. 2022;292(3):409–27. doi: 10.1111/joim.13499 [DOI] [PMC free article] [PubMed]
  • 13.Worldometer [cited 2022 Feb 18]. internet. Available from: https://www.worldometers.info/; Worldometer [internet]. [cited 2022 Feb 18]. Available from: https://www.worldometers.info/
  • 14.Milieustatistieken Environmental statistics. General Bureau of Statistics (ABS) 2014. [cited 2022 Feb 18]. internet. Available from: https://statistics-suriname.org/milieustatistieken-4/; Milieustatistieken [Environmental statistics] [internet]. General Bureau of Statistics (ABS); 2014. [cited 2022 Feb 18]. Available from: https://statistics-suriname.org/milieustatistieken-4/
  • 15.Suriname Communication Service. De boodschap. 2021. [cited 2023 Mar 1]. Available from: https://cds.gov.sr/; Suriname Communication Service. De boodschap. 2021. [cited 2023 Mar 1]. Available from: https://cds.gov.sr/.
  • 16.Malta M, Vettore M, Furtado Passos da Silva C, Baptista Silva A, Strathdee S. The foreseen loss of the battle against COVID-19 in South America: a foretold tragedy. EClinicalMedicine. 2021;39:101068. doi: 10.1016/j.eclinm.2021.101068. [DOI] [PMC free article] [PubMed] [Google Scholar]; Malta M, Vettore M, Furtado Passos da Silva C, Baptista Silva A, Strathdee S. The foreseen loss of the battle against COVID-19 in South America: a foretold tragedy. EClinicalMedicine. 2021;39:101068. doi: 10.1016/j.eclinm.2021.101068 [DOI] [PMC free article] [PubMed]
  • 17.Ministry of Health Suriname Laat je vaccineren. [cited 2022 Feb 23]. Get vaccinated. Available from: https://laatjevaccineren.sr/covid-19-virus-varianten-reeds-in-suriname/; Ministry of Health Suriname. Laat je vaccineren [Get vaccinated]. [cited 2022 Feb 23]. Available from: https://laatjevaccineren.sr/covid-19-virus-varianten-reeds-in-suriname/
  • 18.Starnieuws Suriname heeft voornamelijk met omicron-variant te maken [Suriname is mainly dealing with the omicron variant] Starnieuws. [cited 2022 Feb 21]. Available from: https://www.starnieuws.com/index.php/welcome/index/nieuwsitem/68925.; Starnieuws. Suriname heeft voornamelijk met omicron-variant te maken [Suriname is mainly dealing with the omicron variant]. Starnieuws. [cited 2022 Feb 21]. Available from: https://www.starnieuws.com/index.php/welcome/index/nieuwsitem/68925
  • 19.Ibarra-Nava I, Flores-Rodriguez K, Ruiz-Herrera V, Ochoa-Bayona H, Salinas-Zertuche A, Padilla-Orozco M, et al. Ethnic disparities in COVID-19 mortality in Mexico: a cross-sectional study based on national data. PLoS One. 2021;10(16):e0239168. doi: 10.1371/journal.pone.0239168. [DOI] [PMC free article] [PubMed] [Google Scholar]; Ibarra-Nava I, Flores-Rodriguez K, Ruiz-Herrera V, Ochoa-Bayona H, Salinas-Zertuche A, Padilla-Orozco M, et al. Ethnic disparities in COVID-19 mortality in Mexico: a cross-sectional study based on national data. PLoS One. 2021;10(16): e0239168. doi: 10.1371/journal.pone.0239168 [DOI] [PMC free article] [PubMed]
  • 20.Whitehead M, Taylor-Robinson D, Barr B. Poverty, health, and covid-19. BMJ. 2021;129(372):n376. doi: 10.1136/bmj.n376. [DOI] [PubMed] [Google Scholar]; Whitehead M, Taylor-Robinson D, Barr B. Poverty, health, and covid-19. BMJ. 2021;129(372):n376. doi: 10.1136/bmj.n376 [DOI] [PubMed]
  • 21.World Health Organization . COVID-19 and the social determinants of health and health equity: evidence brief. WHO; 2021. [cited 2022 Feb 22]. Available from: https://apps.who.int/iris/handle/10665/348333. [Google Scholar]; World Health Organization. COVID-19 and the social determinants of health and health equity: evidence brief. WHO; 2021. [cited 2022 Feb 22]. Available from: https://apps.who.int/iris/handle/10665/348333.
  • 22.Giudicessi J, Roden D, Wilde A, Ackerman M. Genetic susceptibility for COVID-19–associated sudden cardiac death in African Americans. Heart Rhythm. 2020;17(9):1487–92. doi: 10.1016/j.hrthm.2020.04.045. [DOI] [PMC free article] [PubMed] [Google Scholar]; Giudicessi J, Roden D, Wilde A, Ackerman M. Genetic susceptibility for COVID-19–associated sudden cardiac death in African Americans. Heart Rhythm. 2020;17(9):1487–92. doi: 10.1016/j.hrthm.2020.04.045 [DOI] [PMC free article] [PubMed]
  • 23.Wise J. Covid-19: known risk factors fail to explain the increased risk of death among people from ethnic minorities. BMJ. 2020;369:m1873. doi: 10.1136/bmj.m1873. [DOI] [PubMed] [Google Scholar]; Wise, J. Covid-19: known risk factors fail to explain the increased risk of death among people from ethnic minorities. BMJ. 2020;369:m1873. doi: 10.1136/bmj.m1873 [DOI] [PubMed]

Articles from Revista Panamericana de Salud Pública are provided here courtesy of Pan American Health Organization

RESOURCES